Highlight 1 in lung cancer
We are honoured to have Dr Kristof Cuppens, a renowned expert in respiratory oncology from Jessaziekenhuis in Hasselt, share his insights on key presentations at the ASCO 2023 congress. Dr. Cuppens has provided us with invaluable commentary on significant studies presented at the conference.
During his commentary, Dr Cuppens discussed the exploratory biomarker analysis of the KEYNOTE-604 study. This study has shown promising potential in identifying specific biomarkers that can help tailor treatment approaches and improve patient outcomes in respiratory oncology.
In addition, Dr. Cuppens shared his thoughts on a dose-escalation trial involving BI764532. This trial focuses on determining the optimal dosage of BI764532 and evaluating its efficacy in respiratory oncology patients.
Furthermore, Dr Cuppens offered his commentary on the SWOG S1929 study, which investigates novel treatment strategies in respiratory oncology.
We are grateful to Dr Kristof Cuppens for his expertise and valuable commentary on these significant presentations at the ASCO 2023 congress.
Make sure to stay updated as we continue to share expert insights from the ASCO 2023 congress.
With the educational support of:
